What Nupsala does

Nupsala Ltd is a UK-based veterinary wholesaler founded in 2012 and headquartered in Melton Mowbray, Leicestershire. The company specialises in musculoskeletal (MSK) treatment products for equine and companion animal veterinary practices, holding dual VMD (WDA5226) and MHRA (WDA(H) 48189) wholesaler approvals that permit distribution of controlled drugs, POM-V products, and imported human-licensed medicines. Its portfolio spans UK and imported veterinary pharmaceuticals, biologics (Intibio A2MG kits, Companion PRP/BMAC, Orthokine IRAP, Magellan PRP, V-Pet Monocytes), topicals, consumables, medical devices, and rehabilitation equipment, and it operates a Mobile Lab service that deploys technical staff and centrifuge equipment into clinics for on-site regenerative medicine procedures.

The business is structured around four integrated revenue streams: pharmaceutical and biologics wholesale via the nupsala.com e-commerce platform and direct sales; a Mobile Lab in-clinic processing service; CPD, wet-lab, and webinar training delivered through conferences (BEVA Congress, London Vet Show) and the nupsala-learning.co.uk platform; and clinical services through MSK Vets, an on-site gait-analysis and regenerative therapy clinic. A proprietary Nupsala StrideSpin Flex™ Centrifuge, co-developed with Drucker Diagnostics, and exclusive UK Intibio A2MG distribution (July 2025) anchor the biologics offering. Distribution is conducted under a 3PL GDP-compliant cold-chain delivery model via Movianto, with regional UK Account Managers covering North, South, and East territories and a dedicated European subsidiary (Nupsala EU) launched in January 2025.

Customers are split between independent veterinary practices and large corporate groups (Medivet, CVS, IVC, Vets4Pets, VetPartners, Linnaeus, XL Vets). The company is founder/owner-operated under CEO Greg McGarrell, with no external institutional investment disclosed, and has grown organically by adding adjacent product categories, exclusive distribution rights, and education-driven demand generation through the Veterinary Osteoarthritis Alliance (VOA), which Nupsala established in 2018.

Name

Nupsala

Legal name

Nupsala Ltd

Website

https://nupsala.com

Company type

Private

Founded year

2012

Operating status

Operating

Headcount range

11–50 employees

Short description

Nupsala Ltd is a UK VMD- and MHRA-approved veterinary wholesaler specialising in musculoskeletal (MSK) biologics, pharmaceuticals, and orthobiologics for equine and companion animal veterinary practices, with complementary Mobile Lab in-clinic processing services and a dedicated European subsidiary (Nupsala EU).

Ownership category

akta.pro rank

Product category

Veterinary Pharmaceuticals Distribution

NAICS

Veterinary Services (541940)

SIC

Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)

akta.pro primary industry

Field Services, Mobile Imaging & On-Farm Procedures (HLAMABAK)

akta.pro secondary industry

Veterinary Regenerative Medicine Manufacturing (GMP/CDMO, Cell Processing) (HLAMANAI)

Keywords

• Veterinary pharmaceuticals
• Veterinary biologics
• Musculoskeletal treatment
• Regenerative medicine
• Veterinary wholesale

Headquarters

HQ city

Melton Mowbray

HQ country

United Kingdom

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Supply Chain, Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure

Revenue model

1. Pharmaceutical and Biologics Wholesale: Wholesale distribution of veterinary pharmaceuticals, biologics, medical devices, and consumables to veterinary clinics. Products include UK licensed veterinary drugs, imported veterinary drugs, human licensed products (supplied to vets for veterinary use), controlled drugs, biologics (PRP, BMAC, stem cells, A2M), medical devices, and rehabilitation equipment.
2. Mobile Lab Service: On-site biological processing service bringing equipment and technical expertise to veterinary clinics. Includes centrifuge hire, PRP kit processing, and BMAC kit processing. No capital outlay required from clinics - equipment and technical assistance provided at customer location.
3. CPD and Training Services: Continuing professional development courses, wet labs, and training sessions for veterinary professionals. Educational platform at nupsala-learning.co.uk offering free online learning resources for veterinary professionals and animal owners.
4. Clinical Services (MSK Vets): MSK Vets clinic providing gait analysis and companion animal therapies. Operates from Melton Mowbray providing advanced musculoskeletal treatments including objective gait analysis, intra-articular therapies, and regenerative medicine.

Pricing tiers

Go-to-market motion2 records

Distribution channels4 records

Marketing channels7 records

Core offering

Nupsala is a VMD- and MHRA-approved UK veterinary wholesaler specialising in musculoskeletal (MSK) treatment products for equine and small animal practices. The company distributes a portfolio of biologics (PRP, BMAC, A2MG, stem cell, IRAP kits), medical devices, controlled drugs, topicals, consumables, and rehabilitation equipment, and complements supply with an in-clinic Mobile Lab biological processing service, CPD/training, and its MSK Vets specialist clinic.

Product overview

Nupsala is a UK-based VMD-approved veterinary wholesaler operating as a platform-plus-services model with a specialist product portfolio focused on musculoskeletal treatment. The core offering includes proprietary and third-party biologics (Intibio A2MG kits, Companion Regenerative Therapies System, Magellan PRP Kit, Orthokine IRAP, V-Pet Monocytes) and the Nupsala StrideSpin Flex™ Centrifuge. These are complemented by consumables (VetScrub, ACD-A), topicals (Cuvestrequin, Zarasyl), and services including Mobile Lab (in-practice biological treatment), Nupsala Learning (CPD platform), MSK Vets (specialist clinic), and VOA (industry association). The company also supplies imported veterinary pharmaceuticals, human licensed products for veterinary use, controlled drugs, and SIC products—primarily for equine and small animal applications. The biologics portfolio is the centerpiece, with processing equipment enabling in-clinic regenerative medicine workflows.

Differentiator

Problem solved

Functional benefit

Brands

• MSK Vets: A musculoskeletal veterinary clinic component of Nupsala offering gait analysis and companion animal therapies, located in Melton Mowbray.
• Nupsala Learning
• Nupsala EU

Products and services

• Nupsala StrideSpin Flex Centrifuge Versatile centrifuge platform developed with Drucker Diagnostics for veterinary orthobiologics processing, supporting orthobiologics, semen processing, and haematocrit applications with universal compatibility across biological products.
• Intibio A2MG 30ml Kit Alpha-2-macroglobulin orthobiologic processing kit that filters plasma proteins from the horse's own blood, isolating A2M and removing harmful proteins. Multi-dose kit with 20ml ACD-A vial, blood draw syringes, and luer lock aliquot syringes; freezable for up to 12 months.
• Intibio A2MG 15ml Kit Compact 15ml version of the alpha-2-macroglobulin filtration processing kit for horses, with the same filtration technology as the 30ml kit and including blood draw and luer lock aliquot syringes.
• Intibio A2MG Plus Animal derivative alpha-2-macroglobulin product for veterinary use in cases of deficiency, delivered frozen in 4ml or 6ml tubes with 24-month shelf life stored at -20°C, -80°C, or in liquid nitrogen.
• Intibio PRP Platelet-rich plasma product delivered frozen in 2ml tubes for veterinary use only, with 24-month shelf life stored at -20°C, -80°C, or in liquid nitrogen.
• Companion Regenerative Therapies System In-house PRP and Bone Marrow Aspirate Concentrate (BMAC) stem cell processing system for small animal practices. Top performing system based on multi-centre canine validation study; centrifuge enables in-practice production for small breed dogs or cats.
• Companion Processing Kits (PRP Kit and BMAC Kit) Disposable processing kits used with the Companion Regenerative Therapies System, including a PRP Kit (platelet-rich plasma for canine use at £197) and a BMAC Kit (bone marrow aspirate concentrate for canine use at £575).
• V-Pet Monocytes Peripheral blood mononuclear cell (PBMC) concentration kit that concentrates monocytes via a non-centrifuge, patient-side processing system. Monocytes differentiate into macrophages or dendritic cells when injected into chronic injury areas.
• Magellan PRP Kit Autologous concentration system delivering concentrated platelets and cells at point of care using proprietary BioAdaptive technology with customizable concentration factors for tailored autologous solutions.
• Orthokine Equine IRAP 60ml IRAP processing kit regarded as the original IRAP/ACS autologous system for producing patient-side IL-1Ra. Requires 24-hour incubation at 37°C and specific centrifuge (incubator and centrifuge available for lease from Nupsala).
• VetScrub Surgical scrubbing consumable product for veterinary use.
• ACD-A Anticoagulant citrate dextrose solution used in blood collection and processing for biologics preparation.
• Cuvestrequin Topical product for equine skin conditions, priced at £33.50 during the summer season.
• Zarasyl Topical veterinary product for animal skin treatment.
• Flexineb Veterinary product for respiratory/nebulizer applications.
• Sidekick Equine Diagnostics Groundbreaking horse-side diagnostic tool from WIMBA (equine motion analysis) distributed through Nupsala UK and EU, enabling point-of-care diagnostics in equine practice.
• Mobile Lab Service In-practice biological regenerative medicine service bringing equipment and a technical team to veterinary clinics for on-site processing of PRP and BMAC samples for tendon/ligament damage, joint disease, and chronic wounds. Pricing includes CRT Centrifuge Hire (price on application, including delivery), CRT PRP Kit (£197), and CRT BMAC Kit (£575).
• Nupsala Learning Free online learning resource for veterinary professionals and animal owners, providing CPD and educational content including webinars on equine osteoarthritis management and regenerative medicine.
• MSK Vets Clinical Service Specialist musculoskeletal veterinary clinic operated from the Melton Mowbray headquarters, providing objective gait analysis, intra-articular injections, stem cell therapies, and polymer hydrogels for companion animal therapies.
• Veterinary Osteoarthritis Alliance (VOA) Industry association for veterinary osteoarthritis education and awareness, established by Nupsala in 2018, providing CPD and training content and hosting lecture sessions.

Quantifiable outcome

• 1000th website order milestone achieved
• +1 more outcomes

Named customers4 records

Segments4 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration2 records

Feature5 records

Partnerships

Eight partnerships are on record, tiered core and minor.

• Veterinary Osteoarthritis Alliance (VOA)coreStrategic or Co-development Partner · 27 October 2025Strategic partnership for education and awareness in veterinary osteoarthritis. Nupsala hosts VOA lecture sessions. VOA established by Nupsala in 2018. Collaboration for CPD and training content.
• Harper Adams UniversityminorStrategic or Co-development Partner · 30 June 2025Host venue for Intra-Articular CPD sessions. Veterinary professionals from across the region attended training sessions at the university.
• WIMBAcoreTechnology or Integration · 30 May 2024Partnership to enhance veterinary care. WIMBA is described as the pioneer in equine diagnostics. Nupsala showcases WIMBA products at conferences (IRVAP Conference 2024, ACPAT Seminar 2024). Products include horse-side diagnostic tools.
• Drucker DiagnosticscoreTechnology or IntegrationCollaboration to develop the Nupsala StrideSpin Flex Centrifuge platform. Builds on Drucker Diagnostics' globally trusted centrifuge systems. Joint product development for veterinary orthobiologics applications.
• Contura (Copenhagen)minorStrategic or Co-development PartnerVisit to Contura's production facility in Copenhagen. Partnership built on passion for veterinary medicine. Commercial team visited to witness production operations.
• Zoetis / University of Pennsylvania New Bolton CenterminorStrategic or Co-development PartnerCollaboration referenced in Intibio A2MG Kit marketing. Zoetis research findings cited regarding comparative orthobiologics performance.
• IntibiocoreTechnology or IntegrationExclusive UK distribution for Intibio A2M processing kits (15ml, 30ml, Plus). Launched July 2025. Previous 4-year partnership with Astaria for equine A2M market.
• MSK VetscoreChannel Partner/ Reseller/ DistributorComponent of Nupsala Veterinary Services. Gait analysis and companion animal therapies clinic. Operates from same Melton Mowbray location. Provides clinical demonstration and treatment services.

Scale indicators5 records

Recent moves8 records

Expansion highlights6 records

Broad incumbents

• Henry Schein Animal Health: Global distributor of veterinary supplies, pharmaceuticals, and equipment serving tens of thousands of animal health practices worldwide. Comparable as a broad-line veterinary wholesaler serving corporate veterinary groups; operates at vastly larger scale and broader product range than Nupsala's specialist MSK focus.
• Elanco Animal Health: Global animal health company offering companion animal and livestock pharmaceuticals, vaccines, and therapeutic products. Comparable as a broad incumbent in veterinary pharmaceuticals with relevant product overlap in pain management and osteoarthritis treatments that compete for the same UK veterinary practice prescribing decisions as Nupsala's MSK portfolio.
• Zoetis: World's largest animal health company with a comprehensive portfolio of pharmaceuticals, vaccines, diagnostics, and biologics across companion animal and livestock. Comparable as the dominant incumbent in veterinary pharmaceuticals and biologics; relevant to Nupsala because Zoetis research on orthobiologic performance is cited in Nupsala's Intibio marketing, indicating competitive overlap in regenerative medicine.

Direct peers

• National Veterinary Services (NVS): One of the largest UK veterinary wholesalers, distributing pharmaceuticals, instruments, and consumables to veterinary practices. Comparable to Nupsala as a B2B veterinary wholesale distributor in the same UK market serving similar clinical customers, though NVS operates at much larger scale and broader product portfolio while Nupsala specializes in MSK biologics.
• Vetoquinol: Independent French veterinary pharmaceutical company with a strong equine and companion animal portfolio including orthobiologics, NSAIDs, and regenerative medicine products. Comparable as a specialty veterinary pharma company with biologics and MSK product overlap; competes in similar UK and European veterinary channels as Nupsala.
• Arthrex Vet Systems: Veterinary division of Arthrex Inc., focused on orthobiologics, regenerative medicine, and orthopedic solutions for equine and small animal practices. Directly comparable to Nupsala in veterinary orthobiologics, PRP, and stem cell processing product portfolio; targets the same veterinary specialist channels with overlapping equine MSK solutions.
• Dechra Pharmaceuticals: UK-headquartered specialty veterinary pharmaceuticals company focused on companion animal and equine endocrinology, dermatology, and musculoskeletal products. Directly comparable to Nupsala in its specialty veterinary pharma focus on MSK and equine segments, though Dechra is a manufacturer-marketer while Nupsala is a distributor-services provider.
• Centaur Services (TVG Group): UK veterinary wholesaler and pharmacy serving independent and corporate veterinary practices across Britain. Comparable to Nupsala as a UK-based B2B veterinary distributor serving similar corporate and independent practice customers, with overlapping pharmaceutical and consumables distribution.

Emerging players

• MediVet Biologics: Veterinary regenerative medicine company offering stem cell and PRP therapy kits for equine and companion animal practices. Comparable to Nupsala's biologics product lines (Intibio, Companion, Magellan) as a competing supplier of in-practice regenerative medicine processing systems; more narrowly focused on biologics with no broad-line wholesale distribution.
• Contura International: Danish veterinary pharmaceutical company producing injectable treatments for osteoarthritis including Arthrosamid and other joint therapies. Comparable as a specialist veterinary manufacturer whose products (referenced via Nupsala's site visit to Contura's Copenhagen facility) compete in the same equine and companion animal joint-care channels as Nupsala's biologics and orthobiologics.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks5 records

Key highlights2 records

Customer concentration

Compliance5 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles10 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Nupsala